Complexity in Early Phase Clinical Trials with Dr. Oren Cohen

Clinical Trial Podcast | Conversations with Clinical Research Experts

Contenuto fornito da Kunal Sampat and Kunal Sampat | Educator. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Kunal Sampat and Kunal Sampat | Educator o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

2y ago 1:20:24

MP3•Pagina principale dell'episodio

When a new drug or device undergoes “first in human” experience, the primary focus is on participant safety. How will the drug or device interact with the human body? And will this interaction be safe?

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials.

To learn more about the complexities in early phase clinical trials, I invited Dr. Oren Cohen, President of Clinical Pharmacology Services and Chief Medical Officer at Labcorp Drug Development on the show.

Dr. Cohen has more than 30 years of healthcare experience which includes his work on clinical development.

I hope you enjoy this conversation with Dr. Oren Cohen.

Podcast Sponsor:

This podcast episode is brought to you by Calyx. Calyx is a trusted name in medical imaging, having delivered imaging services to meet the needs of global biopharmaceutical sponsors and clinical research organizations for over 25 years. To learn more, visit calyx.ai

65 episodi

#Careers #Business #Clinicalresearch #Clinicaltrials #Fitness #Kunal Sampat #Kunal Sampat | Educator #Medicine #Science #CRA